Because OTC is filled with retail and flippers who focus more on hype than actual fundamentals. I will blame it all on OTC. OTC doesn't give us the eyes we need and most of the OTC "whales" are momentum/swing traders.
KAVL isn't a short term play, so why are big retail traders going to tie up their cash when they can trade something much more liquid? The only reason most of us here have so many shares is because we bought in at pennies. I'd be shocked to see someone come forward showing that they bought 100k or 200k shares in the $2 range. (Other than our CEO)
The flipside, on NASD you have institutions who aren't going to flip their shares for 5%, 10% or 20% gains. They are going to buy the shares and sit on them while they appreciate. If the company story continues to move in the right direction, revenue continues, growth and expansion continues, then they may buy even more shares. They will provide us the support we need, and they also lock up their shares.
Again, expansion to 11 new markets and $211k in volume which in turn means higher revenues/profits? Pathetic. I guarantee a bunch of us here own more than what's been traded today.
News 
Market Data 
Discover 
AI
